The Coral Blog
Expert perspectives on policy, performance, and system change.
The Coral Blog is where we break down what’s happening in health care and what it means for leaders working to improve outcomes and affordability. Drawing from our cross-sector experience, we offer commentary that connects the dots between regulation, strategy, and operations.
CMMI’s GLP-1 Model: Why GLP-1s are a Policy Test Case for High-Cost Drugs
GLP-1 therapies have rapidly moved from niche treatments for type 2 diabetes to household names shaping conversations about obesity, cardiovascular risk, and long-term population health. Alongside their rapid uptake has come intense attention from policymakers and payers, who are weighing how to balance affordability, access, and evidence.